ROI Financial Advisors LLC Has $2.55 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

ROI Financial Advisors LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,031 shares of the healthcare conglomerate’s stock after selling 216 shares during the period. UnitedHealth Group comprises approximately 1.7% of ROI Financial Advisors LLC’s investment portfolio, making the stock its 18th biggest position. ROI Financial Advisors LLC’s holdings in UnitedHealth Group were worth $2,545,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Promus Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth $32,000. Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $40,000. Finally, Legacy Investment Solutions LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $57,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $524.94 on Friday. The stock has a fifty day moving average of $509.24 and a 200 day moving average of $542.37. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market capitalization of $480.17 billion, a price-to-earnings ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the business posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on UNH shares. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Finally, Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.